HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine
By Stephanie Brown HealthDay Reporter
FRIDAY, April 25, 2025 -- On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, according to a report from the Associated Press.
This vaccine could be used to combat potential bird flu infections in humans, addressing increasing concerns about the spread of the virus among dairy cows nationwide. Avian influenza A(H5N1), commonly known as bird flu, was detected in dairy cows earlier this year and has since spread to more than 135 herds across 12 states, the AP reported. To date, it has infected three people, all of whom experienced mild cases. Federal health officials are stressing that the risk to the general public remains low.
Moderna is currently in the very early stages of testing a bird flu vaccine using the same mRNA technology that allowed for rapid development and rollout of COVID-19 vaccines. The funds from the U.S. government will enable the ongoing development of the vaccine, including late-stage trials next year, if the results from the early studies prove promising.
HHS officials emphasize that the project can be easily and rapidly redirected to target other forms of influenza if and when different threats emerge.
The award was made possible through the Biomedical Advanced Research and Development Authority, or BARDA, a program that focuses on medical treatments for potential pandemics, the AP said.
Associated Press Article
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
MONDAY, July 21, 2025 -- The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the...
Few Babies Getting RSV Antibody Shot, Beyfortus, Study Says
THURSDAY, July 17, 2025 — A new antibody shot that protects babies against RSV infection could be struggling to gain traction, researchers report. Only about a third (35%)...
WHO, UNICEF Say More Than 14 Million Infants Worldwide Remain Unvaccinated
WEDNESDAY, July 16, 2025 -- Data released this week by the World Health Organization and UNICEF indicate modest gains in childhood vaccination rates, but globally, more than 14...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.